Apellis Pharmaceuticals, Inc. (BIT:1APLS)

Apellis Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,141	3,181	3,973	7,157	5,728	4,611
Market Cap Growth	-32.83%	-19.93%	-44.49%	24.94%	24.23%	5.89%
Enterprise Value	2,146	2,726	3,665	6,910	5,283	4,116
PE Ratio	112.27	125.60	-19.94	-13.45	-8.41	-5.35
PS Ratio	2.50	3.17	5.08	18.05	75.95	69.27
PB Ratio	6.79	8.59	17.38	36.79	33.72	23.21
P/TBV Ratio	6.18	8.81	17.30	36.52	32.30	20.09
P/FCF Ratio	55.84	70.66	-45.01	-12.02	-11.12	-8.17
P/OCF Ratio	55.45	70.17	-45.21	-12.03	-11.15	-8.19
EV/Sales Ratio	2.47	2.72	4.69	17.42	70.05	61.84
EV/EBITDA Ratio	36.81	47.84	-22.46	-13.41	-8.91	-7.70
EV/EBIT Ratio	44.81	49.19	-22.21	-13.36	-8.89	-7.68
EV/FCF Ratio	55.98	60.57	-41.52	-11.60	-10.25	-7.30
Debt / Equity Ratio	0.03	0.03	0.45	0.54	0.63	1.04
Debt / EBITDA Ratio	0.33	0.33	-0.68	-0.21	-0.19	-0.39
Debt / FCF Ratio	0.42	0.42	-1.25	-0.19	-0.22	-0.37
Net Debt / Equity Ratio	-1.21	-1.21	-1.32	-1.24	-2.58	-2.47
Net Debt / EBITDA Ratio	-7.85	-7.85	1.85	0.47	0.74	0.92
Net Debt / FCF Ratio	-9.93	-9.93	3.41	0.40	0.85	0.87
Asset Turnover	1.02	1.02	0.93	0.51	0.09	0.07
Inventory Turnover	0.91	0.91	1.03	0.50	0.11	0.02
Quick Ratio	2.57	2.57	3.65	2.25	3.34	5.39
Current Ratio	3.14	3.14	4.25	3.10	4.29	6.25
Return on Equity (ROE)	79.54%	7.48%	-93.55%	-290.14%	-353.93%	-370.20%
Return on Assets (ROA)	5.25%	5.25%	-19.83%	-67.04%	-72.50%	-58.24%
Return on Invested Capital (ROIC)	15.12%	15.11%	-58.51%	-298.26%	-868.93%	-4551.49%
Return on Capital Employed (ROCE)	7.64%	7.64%	-26.59%	-91.22%	-88.58%	-67.79%
Earnings Yield	0.89%	0.80%	-5.01%	-7.43%	-11.89%	-18.70%
FCF Yield	1.79%	1.42%	-2.22%	-8.32%	-9.00%	-12.24%
Buyback Yield / Dilution	-0.28%	-0.28%	-0.47%	-6.29%	-6.99%	-8.59%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.